French Evaluation Group Avastin Versus Lucentis
NCT01170767
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
501
Enrollment
OTHER
Sponsor class
Conditions
Age Related Macular Degeneration
Interventions
DRUG:
Avastin
DRUG:
Lucentis
Sponsor
Hospices Civils de Lyon